For example, myricetin inhibited the proliferation of T24 bladder cancer cells by down-regulating cyclin B1 and cyclin-dependent kinase cdc2 to induce cell cycle arrest in the G2/M phase [38]. This evidence concerns the gene CDK1 and urinary bladder cancer.